204931-32-8
Chemical Structure
VLHDDLLEA
- CAS No.: 204931-32-8
- Formula:C45H73N11O16
- Molecular Weight:1024.13
InChIKey: FUJDJURUVMMEDF-PFCVTPPASA-N
SMILES: OC([C@H](C)NC([C@H](CCC(O)=O)NC([C@H](CC(C)C)NC([C@H](CC(C)C)NC([C@H](CC(O)=O)NC([C@H](CC(O)=O)NC([C@@H](NC([C@H](CC(C)C)NC([C@@H](N)C(C)C)=O)=O)CC1=CN=CN1)=O)=O)=O)=O)=O)=O)=O
Biological Activity: VLHDDLLEA is a peptide that can be isolated from the MHC complex HLA-A*0201 molecule. VLHDDLLEA can be recognized by HLA-A*0201-restricted cytotoxic T cells (CTLs). VLHDDLLEA can be used for research on graft versus host disease (GvHD)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
VLHDDLLEA | VLHDDLLEA is a peptide that can be isolated from the MHC complex HLA-A*0201 molecule. VLHDDLLEA can be recognized by HLA-A*0201-restricted cytotoxic T cells (CTLs). VLHDDLLEA can be used for research on graft versus host disease (GvHD). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords